May 24 Miragen Therapeutics Inc-
* Miragen Therapeutics receives EU orphan medicinal product designation for MRG-106 for the treatment of cutaneous t-cell lymphoma Source text for Eikon: Further company coverage:
BRIEF-Sanofi and Regeneron announce EU approval for Kevzara
* Sanofi and Regeneron announce approval of Kevzara(®) (sarilumab) to treat adult patients with moderately to severely active rheumatoid arthritis in the European Union
Japan's Takata apologises to victims of faulty air bags
TOKYO, June 27 Japanese auto parts maker Takata Corp apologised on Tuesday to victims of its faulty air bags linked to at least 16 deaths and 180 injuries around the world.